FDA gets comments on track/trace plan; Pharma drives job creation in India;

> Interoperability, coding, data management and authentication top the areas of concern mentioned by stakeholders in response to the FDA's track-and-trace system plan. Story

> Pharma is among the top sectors contributing to the creation of 1.6 million jobs in India 2011, up from 1.13 million in 2010. Story

> Drugmakers face tightening cold chain requirements of national health authorities, notably Brazil, South Korea and Turkey. Story

> Packaging footprint, as well as recyclability and alternatives to PVC and BPA, are currently on the minds of drugmakers. Interview

> Taro Pharmaceutical Industries says it has regained an acceptable regulatory status for its plant in Brampton, Ontario, Canada following an FDA re-inspection. Item

> India's finance ministry and its drug price watchdog disagree over whether industry or consumers should be beneficiaries of a partial excise duty waiver in Jammu and Kashmir. Story

> PREDICT, the FDA's web-based screening program for food and drug imports, is back on track after a setback caused by software problems. Article

> Both Pall and Sartorius Stedim have unveiled single-use aseptic disconnectors. Pall release | Sartorius Stedim release

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)